May 13 (Reuters) - Alpine Immune Sciences Inc ALPN.O :
* ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND
REPORTS
FIRST QUARTER 2021 FINANCIAL RESULTS
* ALPINE IMMUNE SCIENCES - EXPECTS ITS CURRENT CASH
RESOURCES ARE
SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH 2023
* QTRLY BASIC AND DILUTED NET LOSS PER SHARE $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.36, REVENUE VIEW $5.6
MILLION --
REFINITIV IBES DATA
* ALPINE IMMUNE SCIENCES - SEES CURRENT CASH RESOURCES,
POTENTIAL
PRE-OPTION EXERCISE MILESTONES PAYABLE SUFFICIENT TO FUND
PLANNED OPERATIONS THROUGH 2023
Source text for Eikon: ID:nBw4bVy18a
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;))